163 related articles for article (PubMed ID: 9862757)
1. Noncompetitive functional inhibition at diverse, human nicotinic acetylcholine receptor subtypes by bupropion, phencyclidine, and ibogaine.
Fryer JD; Lukas RJ
J Pharmacol Exp Ther; 1999 Jan; 288(1):88-92. PubMed ID: 9862757
[TBL] [Abstract][Full Text] [Related]
2. Antidepressants noncompetitively inhibit nicotinic acetylcholine receptor function.
Fryer JD; Lukas RJ
J Neurochem; 1999 Mar; 72(3):1117-24. PubMed ID: 10037483
[TBL] [Abstract][Full Text] [Related]
3. The "calcium antagonist" TMB-8 [3,4,5-trimethoxybenzoic acid 8-(diethylamino)octyl ester] is a potent, non-competitive, functional antagonist at diverse nicotinic acetylcholine receptor subtypes.
Bencherif M; Eisenhour CM; Prince RJ; Lippiello PM; Lukas RJ
J Pharmacol Exp Ther; 1995 Dec; 275(3):1418-26. PubMed ID: 8531111
[TBL] [Abstract][Full Text] [Related]
4. Effects of steroid exposure on ligand binding and functional activities of diverse nicotinic acetylcholine receptor subtypes.
Ke L; Lukas RJ
J Neurochem; 1996 Sep; 67(3):1100-12. PubMed ID: 8752117
[TBL] [Abstract][Full Text] [Related]
5. Interactions between tachykinins and diverse, human nicotinic acetylcholine receptor subtypes.
Lukas RJ; Eisenhour CM
Neurochem Res; 1996 Oct; 21(10):1245-57. PubMed ID: 8923487
[TBL] [Abstract][Full Text] [Related]
6. Enantioselective effects of hydroxy metabolites of bupropion on behavior and on function of monoamine transporters and nicotinic receptors.
Damaj MI; Carroll FI; Eaton JB; Navarro HA; Blough BE; Mirza S; Lukas RJ; Martin BR
Mol Pharmacol; 2004 Sep; 66(3):675-82. PubMed ID: 15322260
[TBL] [Abstract][Full Text] [Related]
7. Local anesthetics noncompetitively inhibit function of four distinct nicotinic acetylcholine receptor subtypes.
Gentry CL; Lukas RJ
J Pharmacol Exp Ther; 2001 Dec; 299(3):1038-48. PubMed ID: 11714893
[TBL] [Abstract][Full Text] [Related]
8. Bupropion is a nicotinic antagonist.
Slemmer JE; Martin BR; Damaj MI
J Pharmacol Exp Ther; 2000 Oct; 295(1):321-7. PubMed ID: 10991997
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the effects of bupropion on nicotinic receptor-evoked [(3)H]dopamine release from rat striatal synaptosomes and slices.
Sidhpura N; Redfern P; Wonnacott S
Eur J Pharmacol; 2007 Jul; 567(1-2):102-9. PubMed ID: 17477919
[TBL] [Abstract][Full Text] [Related]
10. Bupropion inhibits nicotine-evoked [(3)H]overflow from rat striatal slices preloaded with [(3)H]dopamine and from rat hippocampal slices preloaded with [(3)H]norepinephrine.
Miller DK; Sumithran SP; Dwoskin LP
J Pharmacol Exp Ther; 2002 Sep; 302(3):1113-22. PubMed ID: 12183670
[TBL] [Abstract][Full Text] [Related]
11. Neurochemical and behavioral effects of bupropion and mecamylamine in the presence of nicotine.
Vann RE; Rosecrans JA; James JR; Philibin SD; Robinson SE
Brain Res; 2006 Oct; 1117(1):18-24. PubMed ID: 16949560
[TBL] [Abstract][Full Text] [Related]
12. Characterization of Nicotinic Acetylcholine Receptors Expressed by Cells of the SH-SY5Y Human Neuroblastoma Clonal Line.
Lukas RJ; Norman SA; Lucero L
Mol Cell Neurosci; 1993 Feb; 4(1):1-12. PubMed ID: 19912902
[TBL] [Abstract][Full Text] [Related]
13. Nicotinic modulation of gene expression in SH-SY5Y neuroblastoma cells.
Dunckley T; Lukas RJ
Brain Res; 2006 Oct; 1116(1):39-49. PubMed ID: 16949557
[TBL] [Abstract][Full Text] [Related]
14. Catharanthine alkaloids are noncompetitive antagonists of muscle-type nicotinic acetylcholine receptors.
Arias HR; Feuerbach D; Targowska-Duda KM; Jozwiak K
Neurochem Int; 2010 Sep; 57(2):153-61. PubMed ID: 20493225
[TBL] [Abstract][Full Text] [Related]
15. Nicotinic receptor subtypes in rat hippocampal slices are differentially sensitive to desensitization and early in vivo functional up-regulation by nicotine and to block by bupropion.
Alkondon M; Albuquerque EX
J Pharmacol Exp Ther; 2005 May; 313(2):740-50. PubMed ID: 15647329
[TBL] [Abstract][Full Text] [Related]
16. Synergistic effect of combined treatment with risperidone and galantamine on phencyclidine-induced impairment of latent visuospatial learning and memory: Role of nAChR activation-dependent increase of dopamine D1 receptor-mediated neurotransmission.
Wang D; Noda Y; Zhou Y; Nitta A; Furukawa H; Nabeshima T
Neuropharmacology; 2007 Sep; 53(3):379-89. PubMed ID: 17632185
[TBL] [Abstract][Full Text] [Related]
17. Differential effects of physostigmine and organophosphates on nicotinic receptors in neuronal cells of different species.
van den Beukel I; van Kleef RG; Oortgiesen M
Neurotoxicology; 1998 Dec; 19(6):777-87. PubMed ID: 9863767
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological distinctions between functional nicotinic acetylcholine receptors on the PC12 rat pheochromocytoma and the TE671 human medulloblastoma.
Lukas RJ
J Pharmacol Exp Ther; 1989 Oct; 251(1):175-82. PubMed ID: 2571716
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological characteristics of the inhibition of nondepolarizing neuromuscular blocking agents at human adult muscle nicotinic acetylcholine receptor.
Jonsson Fagerlund M; Dabrowski M; Eriksson LI
Anesthesiology; 2009 Jun; 110(6):1244-52. PubMed ID: 19417616
[TBL] [Abstract][Full Text] [Related]
20. The effects of subunit composition on the inhibition of nicotinic receptors by the amphipathic blocker 2,2,6,6-tetramethylpiperidin-4-yl heptanoate.
Papke RL; Buhr JD; Francis MM; Choi KI; Thinschmidt JS; Horenstein NA
Mol Pharmacol; 2005 Jun; 67(6):1977-90. PubMed ID: 15761116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
